TherapeuticsMD, Inc. (NYSE MKT: TXMD) announced today that it will host its 2014 Investor Day on Monday, June 16, 2014, beginning at 11:30 a.m. EDT at the InterContinental Barclay New York in New York City.
The event will feature a panel of prominent Clinical Key Opinion Leaders, Compounding Market Experts, former FDA Directors, and Legislative and Women’s Health Experts.
For more information and to confirm your attendance, contact Lisa Wilson by phone at 917-543-9932, by e-mail at
or on the home page of the Company's website at
About TherapeuticsMD, Inc.
TherapeuticsMD, Inc. is a women’s healthcare company focused on developing and commercializing products targeted exclusively for women. We are developing advanced hormone therapy pharmaceutical products based on novel technologies that enable delivery of bioidentical hormones through a variety of dosage forms and administration routes. We also manufacture and distribute branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins and cosmetics, under our vitaMedMD
brands. More information is available at the following websites: